Table 5 Treatment emergent adverse events (Safety population N = 160)
67 % NaHCO3 dentifrice + MW (N = 78) | Control dentifrice + MW (N = 82) | |||
|---|---|---|---|---|
n (%) | nAE | n (%) | nAE | |
All AEs | 39 (50.0) | 70 | 41 (50.0) | 72 |
Oral AEs | 21 (26.9) | 24 | 33 (40.2) | 43 |
Treatment Related AEs | 11 (14.1) | 12 | 17 (20.7) | 19 |
Treatment-related oral AEs | ||||
Dysgeusia | 1 (1.3) | 1 | 7 (8.5) | 7 |
Paraesthesia oral | 3 (3.8) | 3 | 4 (4.9) | 4 |
Glossodynia | 2 (2.6) | 2 | 3 (3.7) | 4 |
Tongue discolouration | 4 (5.1) | 4 | 0 | 0 |
Ageusia | 1 (1.3) | 1 | 2 (2.4) | 2 |
Sensitivity of teeth | 1 (1.3) | 1 | 1 (1.2) | 1 |
Hypoaesthesia oral | 0 | 0 | 1 (1.2) | 1 |